General Psychiatry,
Год журнала:
2024,
Номер
37(1), С. e101374 - e101374
Опубликована: Фев. 1, 2024
The
gut
microbiota
is
a
complex
and
dynamic
ecosystem
known
as
the
‘second
brain’.
Composing
microbiota-gut-brain
axis,
its
metabolites
regulate
central
nervous
system
through
neural,
endocrine
immune
pathways
to
ensure
normal
functioning
of
organism,
tuning
individuals’
health
disease
status.
Short-chain
fatty
acids
(SCFAs),
main
bioactive
microbiota,
are
involved
in
several
neuropsychiatric
disorders,
including
depression.
SCFAs
have
essential
effects
on
each
component
axis
In
present
review,
roles
major
(acetate,
propionate
butyrate)
pathophysiology
depression
summarised
with
respect
chronic
cerebral
hypoperfusion,
neuroinflammation,
host
epigenome
neuroendocrine
alterations.
Concluding
remarks
biological
mechanisms
related
will
hopefully
address
clinical
value
microbiota-related
treatments
for
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(11), С. 9577 - 9577
Опубликована: Май 31, 2023
The
human
gut
microbiome
contains
the
largest
number
of
bacteria
in
body
and
has
potential
to
greatly
influence
metabolism,
not
only
locally
but
also
systemically.
There
is
an
established
link
between
a
healthy,
balanced,
diverse
overall
health.
When
becomes
unbalanced
(dysbiosis)
through
dietary
changes,
medication
use,
lifestyle
choices,
environmental
factors,
ageing,
this
profound
effect
on
our
health
linked
many
diseases,
including
metabolic
inflammatory
neurological
diseases.
While
humans
largely
association
dysbiosis
with
disease,
animal
models,
causative
can
be
demonstrated.
brain
particularly
important
maintaining
health,
strong
neurodegenerative
neurodevelopmental
This
suggests
that
microbiota
composition
used
make
early
diagnosis
diseases
modifying
microbiome-gut-brain
axis
might
present
therapeutic
target
for
have
proved
intractable,
aim
altering
trajectory
such
as
Alzheimer's
Parkinson's
multiple
sclerosis,
autism
spectrum
disorder,
attention-deficit
hyperactivity
among
others.
other
potentially
reversible
migraine,
post-operative
cognitive
dysfunction,
long
COVID,
which
considered
models
therapy
disease.
role
traditional
methods
microbiome,
well
newer,
more
novel
treatments
faecal
transplants
photobiomodulation,
are
discussed.
Critical Reviews in Food Science and Nutrition,
Год журнала:
2023,
Номер
64(24), С. 8852 - 8874
Опубликована: Апрель 25, 2023
Gamma-aminobutyric
acid
(GABA)
is
a
naturally
occurring
potential
bioactive
compound
present
in
plants,
microorganisms,
animals,
and
humans.
Especially,
as
main
inhibitory
neurotransmitter
the
central
nervous
system,
GABA
possesses
broad
spectrum
of
promising
bioactivities.
Thus,
functional
foods
enriched
with
have
been
widely
sought
after
by
consumers.
However,
levels
natural
are
usually
low,
which
cannot
meet
people's
demand
for
health
effects.
With
increasing
public
awareness
on
food
securities
processes,
using
enrichment
technologies
to
elevate
contents
instead
exogenous
addition
can
enhance
acceptability
health-conscious
Herein,
this
review
provides
comprehensive
insight
dietary
sources,
technologies,
processing
effects
GABA,
its
applications
industry.
Furthermore,
various
benefits
GABA-enriched
foods,
mainly
including
neuroprotection,
anti-insomnia,
anti-depression,
anti-hypertensive,
anti-diabetes,
anti-inflammatory
also
summarized.
The
challenges
future
research
related
exploring
high
producing
strains,
enhancing
stability
during
storage,
developing
emerging
without
affecting
quality
other
active
ingredients.
A
better
understanding
may
introduce
new
windows
application
foods.
Mediators of Inflammation,
Год журнала:
2023,
Номер
2023, С. 1 - 16
Опубликована: Фев. 8, 2023
Background
and
Object.
There
is
a
growing
body
of
evidence
highlighting
the
significant
role
gut
microbiota
in
various
neurological
psychiatric
disorders.
We
performed
an
mapping
to
review
association
between
different
these
disorders
assessed
strength
for
associations.
Methods.
searched
PubMed,
Cochrane
Library,
Epistemonikos
identify
systematic
reviews
meta-analysis
(SRs).
diseases
disorders,
including
Alzheimer’s
disease
(AD),
attention
deficit
hyperactivity
disorder
(ADHD),
amyotrophic
lateral
sclerosis
(ALS),
autism
spectrum
(ASD),
anorexia
nervosa
(AN),
bipolar
(BD),
eating
(ED),
generalized
anxiety
(GAD),
major
depressive
(MDD),
multiple
(MS),
obsessive
compulsive
(OCD),
Parkinson’s
(PD),
posttraumatic
stress
(PTSD),
spinal
cord
injury
(SCI),
schizophrenia,
stroke.
used
A
Measurement
Tool
Assess
Systematic
Reviews
(AMSTAR-2)
evaluate
quality
included
SRs.
also
created
map
showing
certainty
evidence.
Results.
In
total,
42
studies
were
this
mapping.
Most
findings
obtained
from
observational
studies.
According
AMSTAR-2
assessment,
21
SRs
scored
“critically
low”
terms
methodological
quality,
16
SR
“low,”
5
“moderate.”
total
15
have
been
investigated
potential
microbiome
alpha
diversity
disease,
with
Shannon
index
Simpson
being
most
widely
studied.
12
link
beta
disease.
At
phylum
level,
Firmicutes,
Bacteroidetes,
Actinobacteria,
Proteobacteria,
Verrucomicrobia
more
researched.
genus
Prevotella,
Coprococcus,
Parabacteroides,
Phascolarctobacterium,
Escherichia
Shigella,
Alistipes,
Sutteralla,
Veillonella,
Odoribacter,
Faecalibacterium,
Bacteroides,
Bifidobacterium,
Dialister,
Blautia
Some
found
specific
flora
changes,
some
common
intestinal
microbiological
changes.
Conclusion.
varied
levels
associations
diseases;
increased
risk
diseases,
whereas
others
showed
benefit
that
might
be
promising
therapeutic
targets
such
diseases.
Antioxidants,
Год журнала:
2023,
Номер
12(3), С. 663 - 663
Опубликована: Март 7, 2023
Flavonoids
are
a
biodiverse
family
of
dietary
compounds
that
have
antioxidant,
anti-inflammatory,
antiviral,
and
antibacterial
cell
protective
profiles.
They
received
considerable
attention
as
potential
therapeutic
agents
in
biomedicine
been
widely
used
traditional
complimentary
medicine
for
generations.
Such
medical
herbal
formulations
extremely
complex
mixtures
many
pharmacologically
active
provide
outcome
through
network
pharmacological
effects
complexity.
Methods
emerging
to
determine
the
components
their
targets
decipher
complexities
how
pharmacology
provides
such
effects.
The
gut
microbiome
has
important
roles
play
generation
bioactive
flavonoid
metabolites
retaining
or
exceeding
antioxidative
anti-inflammatory
properties
intact
and,
some
cases,
new
antitumor
antineurodegenerative
bioactivities.
Certain
food
items
identified
with
high
prebiotic
profiles
suggesting
neutraceutical
supplementation
may
be
beneficially
employed
preserve
healthy
population
bacterial
symbiont
species
minimize
establishment
harmful
pathogenic
organisms.
Gut
health
is
an
consideration
effecting
overall
wellbeing
linked
organ
systems.
Bioconversion
generates
can
also
transported
by
vagus
nerve
systemic
circulation
brain
populations
exert
beneficial
effect.
This
particularly
number
neurological
disorders
(autism,
bipolar
disorder,
AD,
PD)
characterized
on
moods,
resulting
depression
anxiety,
impaired
motor
function,
long-term
cognitive
decline.
Native
flavonoids
alleviation
inflammation
tissues,
however,
concerns
raised
levels
not
achieved,
thus
allowing
them
display
optimal
Dietary
manipulation
vagal
stimulation
both
yielded
responses
treatment
autism
spectrum
disorders,
depression,
establishing
route
communication
gut-brain
axis
established
disease
intervention.
While
native
known
penetrate
blood–brain
barrier,
microbiome-generated
(e.g.,
protocatechuic
acid,
urolithins,
γ-valerolactones),
which
retain
antioxidant
potency
addition
promote
mitochondrial
cerebrovascular
microcapillary
should
considered
biotherapeutic
agents.
Studies
warranted
experimentally
examine
efficacy
directly,
they
emerge
novel
options.
General Psychiatry,
Год журнала:
2024,
Номер
37(1), С. e101374 - e101374
Опубликована: Фев. 1, 2024
The
gut
microbiota
is
a
complex
and
dynamic
ecosystem
known
as
the
‘second
brain’.
Composing
microbiota-gut-brain
axis,
its
metabolites
regulate
central
nervous
system
through
neural,
endocrine
immune
pathways
to
ensure
normal
functioning
of
organism,
tuning
individuals’
health
disease
status.
Short-chain
fatty
acids
(SCFAs),
main
bioactive
microbiota,
are
involved
in
several
neuropsychiatric
disorders,
including
depression.
SCFAs
have
essential
effects
on
each
component
axis
In
present
review,
roles
major
(acetate,
propionate
butyrate)
pathophysiology
depression
summarised
with
respect
chronic
cerebral
hypoperfusion,
neuroinflammation,
host
epigenome
neuroendocrine
alterations.
Concluding
remarks
biological
mechanisms
related
will
hopefully
address
clinical
value
microbiota-related
treatments
for